Evidence map›Paper›PMID 30916387›Full record

ArticleClinical and experimental immunology2019

Tissue talks: immunophenotype of cells infiltrating the graft explains histological findings and the benefits of belatacept at 10 years.

J Furuzawa-Carballeda, N O Uribe-Uribe, J M Arreola-Guerra, R Reyes-Acevedo, M Vilatobá, A López-Toledo, G Mondragón-Salgado, R Chávez-Fernández, F López-Verdugo, G Mondragón-Ramírez and 1 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Clinical and experimental immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. CD4Frontiers in immunology · 2022
    Review
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

J Furuzawa-CarballedaDepartment of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID 0000-0001-5804-7221
N O Uribe-UribeDepartment of Pathology and Anatomic Pathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
J M Arreola-GuerraDepartment of Transplantation, Centenario Hospital Miguel Hidalgo, Aguascalientes, Mexico.ORCID 0000-0001-7430-702X
R Reyes-AcevedoDepartment of Transplantation, Centenario Hospital Miguel Hidalgo, Aguascalientes, Mexico.
M VilatobáDepartment of Transplantation, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
A López-ToledoInstituto Mexicano de Trasplantes, Cuernavaca, Morelos, Mexico.
G Mondragón-SalgadoInstituto Mexicano de Trasplantes, Cuernavaca, Morelos, Mexico.
R Chávez-FernándezDepartment of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
F López-VerdugoDepartment of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
G Mondragón-RamírezInstituto Mexicano de Trasplantes, Cuernavaca, Morelos, Mexico.
J AlberúDepartment of Transplantation, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID 0000-0002-8271-1353
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previously, we found a substantial number of regulatory T cells (T

Indexed as

AbataceptAdultCD4 Lymphocyte CountCellular SenescenceCyclosporinsFemaleGlomerular Filtration RateGraft SurvivalHumansImmunophenotypingImmunosuppressive AgentsKidney TransplantationMaleMexicoTacrolimusTh17 CellsAbataceptCyclosporinsImmunosuppressive AgentsTacrolimusbelataceptinflammatory/regulatory cellsinterstitial fibrosiskidney transplanttubular atrophy

Identifiers

PMID30916387
PMCPMC6642879
OpenAlexW2923878059

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.